Skip to main content

FDA Approves First Absorbable Stent for Coronary Artery Disease

Medical Worker Provider in Home with Senior Patients

On July 5, 2016, the U.S. Food and Drug Administration (FDA) approved the Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), the first absorbable stent for coronary artery disease, which releases the drug everolimus to limit the growth of scar tissue and is gradually absorbed by the body in approximately three years.